|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/513 | |
| A61K 31/53 | |||
| A61K 31/5025 | |||
| A61K 31/4184 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3102199 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15740207.4 |
| Europos patento paraiškos padavimo data | 2015-01-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-12-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/012244 |
| Data | 2015-01-21 |
| (87) | Numeris | WO 2015/112598 |
| Data | 2015-07-30 |
| (30) | Numeris | Data | Šalis |
| 201461929680 P | 2014-01-21 | US |
| (72) |
RASSOOL, Feyruz, US
BAYLIN, Stephen, US
ROBERT, Carine, FR
|
| (73) |
The Johns Hopkins University,
3400 North Charles Street, Baltimore, MD 21218,
US
University of Maryland, Baltimore, Office of Technology Transfer 620 W.Lexington Street, 4th Floor, Baltimore MD 21201, US |
| (54) | THERAPY REGIMEN AND METHODS TO SENSITIZE CANCER CELLS TREATED WITH EPIGENETIC THERAPY TO PARP INHIBITORS IN MULTIPLE CANCERS |
| THERAPY REGIMEN AND METHODS TO SENSITIZE CANCER CELLS TREATED WITH EPIGENETIC THERAPY TO PARP INHIBITORS IN MULTIPLE CANCERS |